Division of Chemical Biology and Medicinal Chemistry, University of North Carolina, Chapel Hill, North Carolina 27599, USA.
J Biol Chem. 2013 Feb 22;288(8):5840-8. doi: 10.1074/jbc.M112.422501. Epub 2013 Jan 7.
Phospholipase C (PLC) isozymes are important signaling molecules, but few small molecule modulators are available to pharmacologically regulate their function. With the goal of developing a general approach for identification of novel PLC inhibitors, we developed a high-throughput assay based on the fluorogenic substrate reporter WH-15. The assay is highly sensitive and reproducible: screening a chemical library of 6280 compounds identified three novel PLC inhibitors that exhibited potent activities in two separate assay formats with purified PLC isozymes in vitro. Two of the three inhibitors also inhibited G protein-coupled receptor-stimulated PLC activity in intact cell systems. These results demonstrate the power of the high-throughput assay for screening large collections of small molecules to identify novel PLC modulators. Potent and selective modulators of PLCs will ultimately be useful for dissecting the roles of PLCs in cellular processes, as well as provide lead compounds for the development of drugs to treat diseases arising from aberrant phospholipase activity.
磷酸脂酶 C(PLC)同工酶是重要的信号分子,但可用的药理学调节其功能的小分子调节剂很少。为了开发鉴定新型 PLC 抑制剂的通用方法,我们开发了一种基于荧光底物报告物 WH-15 的高通量测定法。该测定法高度灵敏且重现性好:对包含 6280 种化合物的化学文库进行筛选,鉴定出三种新型 PLC 抑制剂,它们在体外两种分离的 PLC 同工酶的测定法中表现出很强的活性。三种抑制剂中的两种也抑制了完整细胞系统中 G 蛋白偶联受体刺激的 PLC 活性。这些结果表明高通量测定法在筛选大量小分子以鉴定新型 PLC 调节剂方面的强大功能。PLC 的有效且选择性调节剂最终将有助于剖析 PLC 在细胞过程中的作用,以及为开发用于治疗异常磷脂酶活性引起的疾病的药物提供先导化合物。